The funding from Blackstone Life Sciences and the positive c...
The funding from Blackstone Life Sciences and the positive clinical trial data from Moderna's new vaccines could potentially boost the company's stock, which has been underperforming in the past year due to falling Covid-19 vaccine sales.
Moderna Gets $750 Million for Flu Program. Funding to Help Move Beyond Covid Vaccines. -- Barrons.com
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment